Press release
Biosimilar Market size was valued at USD 24.86 Billion in 2023 and the total Biosimilars revenue is expected to grow at a CAGR of 17.02 % from 2024 to 2030, reaching nearly USD 74.70 Billion by 2030.
Biosimilar Market
The biosimilar market, involving the production of highly similar and functionally identical versions of approved reference biologics, is explored in-depth in the comprehensive report by Maximizing Market Research Pvt Ltd. The report provides insights into the market dynamics, drivers, restraints, and regional perspectives, offering a thorough understanding of the evolving landscape.
The report employs a robust research methodology, combining qualitative and quantitative approaches, to provide accurate and reliable data. In-depth market analysis, industry expert interviews, and comprehensive data validation contribute to the credibility of the research findings.
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/83592
Biosimilar Market Dynamics:
The biosimilar market is propelled by factors such as patent expirations of biologic drugs, rising healthcare costs, and the growing demand for accessible treatments. Key players like Pfizer, Sandoz (Novartis), Amgen, and Biocon are driving innovation and reshaping the landscape of healthcare options through strategic alliances and regulatory approvals.
Biosimilar Market Regional Insights:
Europe and North America lead in biosimilar manufacturing, with established regulatory frameworks and robust infrastructure. Asia-Pacific, including countries like India and South Korea, is emerging as a significant manufacturing hub, contributing substantially to global exports.
Request For Free Inquiry Report:https://www.maximizemarketresearch.com/inquiry-before-buying/83592
Biosimilar Market Segmentation:
by Type
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Granulocyte-colony stimulating factor
Others
by Application
Oncology
Inflammatory
Autoimmune diseases
Chronic diseases
Blood disorders
Growth hormone deficiency
Infectious diseases
Other
by Technology
Recombinant DNA Technology
Monoclonal Antibodies (MAb) Technology
by End-User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Biosimilar Market Key Players:
North America:
1. Pfizer Inc.
2. Amgen Inc.
3. Coherus BioSciences
4. Viatris (formerly Mylan)
5. Teva Pharmaceutical Industries
Europe:
1. Novartis AG (Sandoz)
2. Biocon Biologics
3. Samsung Bioepis
4. Fresenius Kabi
5. Biogen
Asia-Pacific:
1. Biocon Biologics
2. Samsung Bioepis
3. Celltrion Inc.
4. Dr. Reddy's Laboratories
5. Lupin Limited
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report :https://www.maximizemarketresearch.com/market-report/global-biosimilar-and-follow-on-biologics-market/83592/
Table of content for the Biosimilar Market includes:
1. Global Biosimilar Market: Research Methodology
2. Global Biosimilar Market: Executive Summary
Market Overview and Definitions
Introduction to the Global Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry
3. Global Biosimilar Market: Competitive Analysis
MMR Competition Matrix
Market Structure by region
Competitive Benchmarking of Key Players
Consolidation in the Market
M&A by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact
4. Company Profile: Key players
Company Overview
Financial Overview
Global Presence
Capacity Portfolio
Business Strategy
Recent Developments
Key Offerings:
Past Market Size and Competitive Landscape
Past Pricing and price curve by region
Market Size, Share, Size and Forecast by different segment | 2023-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation - A detailed analysis by growth and trend
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
Related Report Published by Maximize Market Research :
Global Organic Food Market https://www.maximizemarketresearch.com/market-report/global-organic-food-market/87324/
Vision Positioning Market https://www.maximizemarketresearch.com/market-report/global-vision-positioning-market/31137/
Global Public Safety and Security Market https://www.maximizemarketresearch.com/market-report/public-safety-security-market/647/
Alternative Protein Market https://www.maximizemarketresearch.com/market-report/global-alternative-protein-market/52719/
Global Paper Packaging Materials Market https://www.maximizemarketresearch.com/market-report/paper-packaging-materials-market/122220/
Compound Feed Market https://www.maximizemarketresearch.com/market-report/compound-feed-market/196236/
Liquid Biopsy Market https://www.maximizemarketresearch.com/market-report/global-liquid-biopsy-market/3261/
Global White Box Server Market https://www.maximizemarketresearch.com/market-report/global-white-box-server-market/65959/
Clinical Chemistry Analyzer Market https://www.maximizemarketresearch.com/market-report/global-clinical-chemistry-analyzer-market/22852/
Global Real-time Systems Market https://www.maximizemarketresearch.com/market-report/global-real-time-systems-market/108630/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilar Market size was valued at USD 24.86 Billion in 2023 and the total Biosimilars revenue is expected to grow at a CAGR of 17.02 % from 2024 to 2030, reaching nearly USD 74.70 Billion by 2030. here
News-ID: 3342047 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Digital Transformation Market to Grow at a Staggering 23.6% CAGR, Targeting Near …
Digital Transformation Market size was valued at USD 634.06 billion in 2023 and the total Global Digital Transformation revenue is expected to grow at a CAGR of 23.6 % from 2024 to 2030, reaching nearly USD 2794.24 billion.
Digital Transformation Market Overview:
The digital transformation market encompasses the vast and rapidly evolving ecosystem of technologies, services, and strategies that organizations adopt to fundamentally change their operations, value delivery, and customer engagement through…
Ginger Market to Grow at a Steady 3.15% CAGR, Targeting USD 9.87 Billion Revenue …
Ginger Market size was valued at USD 7.70 Billion in 2024 and the total Ginger revenue is expected to grow at a CAGR of 3.15% from 2025 to 2032, reaching nearly USD 9.87 Billion.
Ginger Market Overview:
The ginger market is a substantial and vital segment of the spice industry, characterized by its dual role as a staple culinary ingredient and a revered medicinal commodity. Ginger, derived from the rhizome of the…
Acai Berry Market to Grow at an 11.5% CAGR, Targeting USD 18.41 Billion Revenue …
Acai Berry Market size was valued at USD 7.70 Billion in 2024 and the total Acai Berry revenue is expected to grow at a CAGR of 11.5% from 2025 to 2032, reaching nearly USD 18.41 Billion.
Acai Berry Market Overview:
The acai berry market is a dynamic and rapidly growing segment within the superfoods industry, driven by increasing consumer awareness of its high nutritional value and antioxidant properties. Originating from the Amazon…
Coffee Market to Grow at a 6.2% CAGR, Targeting USD 223.25 Billion Revenue by 20 …
Coffee Market size was valued at USD 137.97 Billion in 2024 and the total Coffee revenue is expected to grow at a CAGR of 6.2% from 2025 to 2032, reaching nearly USD 223.25 Billion.
Coffee Market Overview:
The coffee market is a massive and mature agricultural industry, representing one of the world's most traded commodities, second only to oil in some measures. It encompasses the entire supply chain from cultivation and processing…
More Releases for Biosimilar
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
